Companion “high THC” legislation was readied for the Senate, five additional bills were scheduled for committee actions, and two bills were poised for movement on Monday.
Here are some observations of the Washington State Legislature (WA Legislature) for Monday January 15th, the 8th day of the 2024 regular session.
My top 3 takeaways:
- An identical companion to the newest “high THC” bill by Representative Lauren Davis was scheduled to be introduced by Senator Jesse Salomon on Monday.
- SB 6220 - “Concerning high THC cannabis products.”
- Senator Salomon was joined by initial co-sponsors Sharon Shewmake (also a democrat), Republican Floor Leader Shelly Short, and Republican Whip Keith Wagoner.
- The bill was companion legislation to HB 2320, introduced by Davis on Thursday January 11th. HB 2320 was scheduled to receive its initial public hearing on Tuesday January 16th in the Washington State House Regulated Substances and Gaming Committee (WA House RSG).
- In the fall of 2022, Salomon joined Davis for a speaking engagement on concentrated cannabis products at the University of Washington Addictions, Drug, and Alcohol Institute (UW ADAI) Symposium on “High-THC Cannabis in Legal Regulated Markets” during which the senator speculated on the “veto power” cannabis stakeholders had over legislation in the sector, and that lawmakers should consider what's best for communities rather than being stridently pro- or anti-cannabis legalization.
- UW ADAI staff published a paper in December funded by a $500K budget proviso in 2021 which I called out in comments to WSLCB board members on January 3rd for its conclusion that “Future studies should explore non-cannabis industry stakeholders’ willingness to work towards minimizing the influence of the cannabis industry in policy development processes to assure public health regulations prevail.”
- Notably, the bill was scheduled for referral to the Washington State Senate Health and Long Term Care Committee (WA Senate HLTC) rather than the primary cannabis policy committee in the Senate, the Washington State Senate Labor and Commerce Committee (WA Senate LC).
- During the April 20th, 2023 UW ADAI webinar titled, “Addressing the Risks of High THC Cannabis: The Public Health and Legislative Saga,” UW ADAI Research Scientist and Cannabis Education and Research Program (CERP) Director Bia Carlini was asked by a participant whether lawmakers hearing the bills held “a conflict of interest.” Carlini alleged “among legislators that are in the public health domain, there is a strong movement to try to move cannabis out of a committee that is originally concerned with commerce towards health, and that would probably give a different flavor on how this bill would have fared.” She said the committees overseeing the adult-use cannabis market had been “a very major barrier” (audio - 3m, video).
- SB 6220 - “Concerning high THC cannabis products.”
- At the end of the prior week, several additional bills were scheduled for committee actions during the upcoming second week of the 2024 regular session.
- HB 1341 - "Concerning cannabis license ownership."
- The House version of the out-of-state ownership bill from 2023 was scheduled for a public hearing on Tuesday January 16th in the WA House RSG. The legislation, which would also suspend inactive producers, received mostly supportive testimony when it was first heard in January 2023, with opposition centered on equity implications from the change.
- WA House RSG Co-Chair Sharon Wylie told participants at the Washington CannaBusiness Association (WACA) 2023 Symposium that “I'm going to be pushing my bill for out-of-state investors,” indicating she’d seen less pushback on the matter. She claimed the ownership restriction had been intended to “protect the new industry here from big pharma and big tobacco buying up all the licenses and putting all of our own people out of business…that didn't happen, and it hasn't happened in any other state.” For this reason, Wylie planned “to push more with that and do the best I can.”
- SB 5377, companion legislation in the Senate which had been amended and advanced much farther, remained quarantined in the Washington State Senate Rules Committee (WA Senate RULE) x-file at publication time.
- HB 2255 - “Concerning inversion and diversion of cannabis.”
- Following its introduction on Wednesday January 10th, members of WA House RSG added an initial public hearing on the legislation to their Thursday January 18th meeting at 8am PT.
- HB 2320 - “Concerning high THC cannabis products.”
- An initial public hearing on the legislation was scheduled for Tuesday January 16th.
- HB 2334 - “Transferring certain cannabis licensing activities to the department of agriculture.”
- Following its introduction on Friday January 12th, an initial public hearing was scheduled on the legislation for Thursday January 18th.
- SB 5404 - “Increasing cannabis revenue distributions to local governments.”
- Somewhat unusually, an executive session was scheduled in WA Senate LC on Tuesday January 16th - but no public hearing had been held on the 2023 legislation. Most likely, this means members intend to refer the bill to a different committee.
- On Tuesday January 9th, WA House RSG members heard testimony from representatives of local governments who downplayed the importance to elected officials of excise, sales, and use tax revenue from the sale of cannabis in local jurisdictions.
- During their January 4th meeting, members of the Washington State Joint Legislative Audit and Review Committee (JLARC) accepted a final report on “Appropriations and Expenditures of the Dedicated Cannabis Account” which indicated that 239 local governments received 3% of all State excise tax revenue collected from the sale of regulated cannabis products between 2015 and 2023 totaling $102.157M.
- HB 1341 - "Concerning cannabis license ownership."
- The Washington State House Regulated Substances and Gaming Committee (WA House RSG) was scheduled to convene on Monday afternoon and planned to hear the Washington State Department of Agriculture (WSDA) request legislation to take on cannabis testing lab accreditation authority and potentially recommend the low-dose THC beverage bill (again).
- 1:30pm: WA House RSG - Committee Meeting
- Public Hearing
- HB 2151 - “Reassigning the accreditation of private cannabis testing laboratories from the department of ecology to the department of agriculture.”
- Executive Session
- HB 1249 - “Regarding limits on the sale and possession of retail cannabis products.”
- During the second public hearing on HB 1249 hosted on Tuesday January 9th, representatives from The Cannabis Alliance, the Washington CannaBusiness Association (WACA), and the Painted Rooster Cannabis Company spoke unanimously and persuasively in support of expanding infused beverage product options beyond low volume, more concentrated form factors.
- HB 1249 - “Regarding limits on the sale and possession of retail cannabis products.”
- Public Hearing
- 1:30pm: WA House RSG - Committee Meeting